SUNPHARM Pharmaceuticals (SUNP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SUNPHARM Pharmaceuticals (SUNP)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JMarcus who wrote (29)	2/2/1999 7:22:00 PM
From: celeryroot.com	Read Replies (1) of 52

" Targets of the Phase 2 trial of DENSPM: ovarian, melanoma, pancreatic, non-small cell lung, renal cell carcinoma, and colon cancer." Why not explain to us all these targets in 1 phase 2? " Possible to advance to NDA without P-3 trials: It the statistical results of the P-2 trial are strong enough, this is a real possibility." Dream on. How do you think this is even possible?????

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next